Osteomalacia was induced in rats fed a diet containing 50,000 ppm (5%) iron lactate for 13 weeks. The histopathology and histomorphometrical dynamics of osteoblasts under this condition were examined. Bone histomorphometry of the proximal tibial metaphysis revealed that the osteoblast surface, osteoid volume, osteoid surface and labeled surface ratio, which are the parameters of bone formation had increased. The blood chemistry revealed the greatest elevation in the osteocalcin level; however, the parathyroid hormone (PTH) secretion and inorganic phosphorus level were very low. From the serum biochemical, histopathological and histomorphometrical findings, the bone lesion in iron lactate-overloaded rats was considered to be similar to low turnover osteomalacia showing decreased trabeculae in secondary spongiosa and increased lamellar osteoid. Furthermore, an ironpositive reaction was detected at the interface between osteoid and mineralized bone. In the bone lesions induced by chronic iron overload, osteoblast recruitment exceeded that of mineralization or, alternatively, the iron within osteoblasts along the trabecular bone suppressed the remodeling and led to an increase in osteoid thickness.
INTRODUCTION
Osteomalacia is bone change characterized by decreased calcium deposition of the bone trabecular and nonmineralized osteoid accumulating on the bone surface in layers of excessive thickness. Osteomalacia is known to be induced by many factors, that is, vitamin D deficiency, malabsorption, disturbance of di-hydroxylation of vitamin D 3 , excessive inactivation of vitamin D metabolites, phosphate deficiency (especially iron and aluminum) and in situ inhibition of mineralization (25) . In diseased animals (conditions), serum levels of calcium, phosphorus, or active vitamin D are decreased, and osteoblasts cannot produce sufficient alkaline phosphatase (18) . Osteomalacia in patients on long-term hemodialysis have been associated with aluminum accumulation in bone (10) . Aaron et al elucidated the etiology of aluminum-induced osteomalacia showing that aluminum reduced the rate of direct hydroxyapatite formation and transformation of amorphous calcium phosphate to hydroxyapatite, and the crystal growth rate of hydroxyapatite seed (23) . Iron might effect growth of hydroxyapatite as an additional means of causing osteomalacia.
Low serum phosphate and parathyroid hormone (PTH) levels are also observed in older maintenance hemodialysis patients with decreased protein intake who present a higher incidence of adynamic bone disease, have lower PTH levels, and require lower doses of phosphate binders to achieve adequate control of phosphorus levels (13) . Fournier et al have reviewed the possible cases of adynamic bone diseases and proposed hypophosphatemia as a potential etiologic factor, which could have an inhibitory effect on bone formation by decreasing PTH secretion (8) .
We have already shown that 2-week administration of excess iron lactate induces characteristic osteopenia in rats, characterized by about 70% low body weight and eosinophilic gastroenterocolitis, which can also be induced in rats by 3-month administration of iron lactate (15, 16) . To investigate the pathogenesis of osteomalacia and the differences in bone changes from short and intermediate duration of exposure to iron lactate, we compared the morphological features and osteoblast dynamics between 3-month iron-lactate overloaded and control rats.
MATERIALS AND METHODS
Animals and Diet: Twenty-five male Sprague-Dawley rats were obtained at 4 weeks of age from Ishibe Breeding Laboratory, Clea Japan Inc, and were acclimatized for 12 days until the start of the study. The 20 rats were divided into 2 groups of 10 each, receiving 0 or 50,000 ppm iron lactate (C 9 H 16 O 9 Fe·H 2 O, bivalent iron ions; 17.56%, trivalent iron ions; 0.04%, Musashino Chemical; Japan) in a commercial diet (CRF-1, Oriental Yeast; Japan) for 13 weeks. The remaining rats (n = 5) were assigned the restricted diet group that was fed 60% of the control food intake according to the design in study of Narama (16, 17) . The rate of food intake was greater than the quantity eaten by the iron lactate group. Five animals were adequate to analyze the change of bone volume caused by the decrease of food consumption.
The admixed diet was insufflated with nitric gas and kept sealed in light-resistant containers at 4 • C to prevent oxidation before feeding. Body weight was measured once weekly and IRON LACTATE OSTEOMALACIA IN RATS 647 food consumption was measured two times weekly throughout the experimental periods. In the iron lactate groups, all rats were administered 20 mg/kg tetracycline hydrochloride (Nacalai Tesque, Inc; Japan) subcutaneously to double-label the bone at 5 and 2 days before necropsy. The rats were cared for according to the principles outlined in the guide for the care and use of laboratory animals prepared by the Japanese Association for Laboratory Animal Science and our institution.
Blood Biochemistry: Blood samples were collected from the posterior vena cava of all rats under pentobarbital sodium anesthesia (Nembutal injection, Dainippon Pharmaceutical Co, Ltd; Japan) and treated with heparin sodium (Mitsubishi Pharma Co, Ltd; Japan) at the end of the study. Blood chemistry parameters were examined with an automated analyzer (Hitachi 7170; Japan); total protein, creatinine, inorganic phosphorus, iron, urea nitrogen, alkaline phosphates, and calcium (only iron lactate and control groups had urea nitrogen, alkaline phosphatase, and calcium analyzed). Urea nitrogen, alkaline phosphatase, and calcium were not measured in the restricted diet group. Osteocalcin and PTH were measured with commercially available radioimmunoassay kits (Biochemical Technologies Inc, USA and Nichols Institute Diagnostics, USA). To assure validity of the assay, we included samples with known levels of rat osteocalcin and PTH.
Urinalysis: The day before the end of each study period, all rats were placed in individual metabolic cages, and 4-hour urine samples were collected from the rats deprived of food. Creatinine, iron, inorganic phosphorus and calcium in urine were measured with an automated analyzer (Environmental Biological Life Science Research Center Inc, Japan).
Tissue Histopathology and Bone Histomorphometry: The tibia was fixed in 10% neutral buffered formalin and dehydrated with graded alcohol solution, and embedded in methyl methacrylate (Osteo-Bed, Polyscience, Inc, UK). Undecalcified plastic specimens of the proximal tibia were cut into 3-µm-thick sections (Rotary Microtome HM 350, Microm, Germany) and stained with Masson Goldner's trichrome then with Berlin blue for ferric iron for the histopathological and histomorphometrical examination.
Thyroid gland, parathyroid glands, liver, kidney, esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, and rectum were routinely processed and embedded in paraffin. These paraffin sections were stained with hematoxylin and eosin and Berlin blue for ferric iron and examined microscopically.
Histomorphometry of the proximal tibial metaphysis was performed using a computer-digitizing image system consisting of a light microscope with a camera (Fuji HC-2000, Fujifilm, Japan), a flat scanner (ScanMaker, Microtek, Japan) and software (Image-Pro Plus, Media Cybernetics, USA). An area of about 6 mm 2 of secondary spongiosa was measured in the central proximal tibial metaphysis beginning at 1 mm distal to the growth plate-metaphyseal junction. Histomorphometric parameters were measured and ratios calculated for the undecalcified sections included the following: bone volume/tissue volume (BV/TV), osteoid volume/bone volume (OV/BV), osteoid surface/bone surface (OS/BS), osteoblast surface/bone surface (Ob.S/BS), eroded surface/bone surface (ES/BS), os-teoclast number per mm of bone surface (N.Oc/BS), osteoclast surface/bone surface (Oc.S/BS) as static parameters; trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp) for the architecture; and percent labeled perimeter (%L Pm), mineral apposition rate (MAR), mineralization lag time (MLT) as kinetic parameters (19, 20) . Tb.Th, Tb.N, and Tb.Sp were used for Parfitt's equation (21) . The kinetic parameters were measured from photomicrographs of the single-and double-labeled surface, which were taken under fluorescent light (only for iron lactate and control groups because the diet restricted group was designed to mainly observe the influence of bone volume from a decrease of food consumption). The mineral apposition rate was calculated by dividing the labeling width by the number of days between the double labels with tetracycline hydrochloride.
Statistical Analysis: All data are expressed as the mean ± SD in the tables. Body weight and food consumption was analyzed by two-way ANOVA. Body weight, food consumption, blood chemistry, urinalysis and bone histomorphometric parameters were also analyzed by Dunnett's multiple comparison procedure between the control group and the 13-week exposure group or the restricted diet group. The probability level was set at 0.05 or 0.01 for the criteria of significance.
RESULTS

Body Weight and Food Consumption (Tables 1 and 2):
Throughout the experimental period, the body weight of the iron lactate exposure group and the restricted diet group was significantly lower than that of the control group, respectively. The body weights of the restricted diet group were almost comparable to the iron lactate exposure group for most measurements. Food consumption of the iron lactate exposure group was also significantly lower than that of the control group.
Blood Biochemistry and Urinalysis (Tables 3 and 4 ): Osteocalcin (+81%) as a marker of bone formation and calcium (+19%) were significantly higher, while PTH (−85%) was significantly lower than those of the control group, respectively. Serum urea nitrogen was significantly higher than that of the control group. Serum total protein was a little decreased compared with the control group. Serum iron and calcium were also significantly higher, while inorganic phosphorus was significantly lower than those of the control group, respectively. Serum calcium, alkaline phosphatase, and urea nitrogen of the restricted diet group were not measured because, these values in males of the 50% restricted diet of control did not differ from the control group (12) . Therefore, it was thought that this study was not affected by these omissions.
In the iron lactate exposure group, urea iron and calcium were significantly higher by 70-fold and 18-fold, respectively, and inorganic phosphorous was also 99.8% significantly lower than those of the control group. Creatine ratios for these parameters were also significantly higher than those of the control group. In the restricted diet group, no particular changes were observed.
Tissue Histopathology and Bone Histomorphometry ( Table 5) : Iron lactate caused a decline of the trabecula and an reactions for increase in the size of the osteoid Group 0 week (g) 1 week (g) 2 weeks (g) 3 weeks (g) 4 weeks (g) 5 weeks (g) 6 weeks (g) 7 weeks (g) 8 weeks (g) 9 weeks (g) 10 weeks (g) 11 weeks (g) 12 weeks (g) 13 seam in the secondary spongiosa of the tibia (Figures 1-4 ). Positive iron ions (Ferric irons) were detected on the edge of the all trabecular surface in the tibia by Berlin blue staining. Lining iron deposits were also present at the osteoidmineralized bone interface ( Figure 5 ). However, no iron deposition was observed in the osteocytes and parathyroid glands.
In the iron lactate-exposure group, eosinophilic infiltration, increased number of globule leukocytes, and accumulation of macrophages engulfing the brown pigment were observed in the lamina propria of the alimentary tract. A small amount of Berlin blue positive granules was observed in the proximal tubular epithelium of the kidney. Single cell necrosis of hepatocyte and hemosiderin deposition was also observed in the liver. No remarkable changes were observed in the bone and parathyroid glands of the restricted diet group.
In the iron lactate exposure group, the static parameters such as the osteoid volume and osteoid surface were significantly higher by 3.4-fold and 3.1-fold than those of the control group, respectively. The osteoblast surface (+60%), eroded surface (+7%) and trabecular separation (+43%) were also significantly higher than those of the control group, respectively. On the other hand, the bone volume (−20%) was low in comparison with the control group. As the kinetic parameter, MLT was significantly higher by 7.1-fold and the percent labeled perimeter (+64%) was significantly higher than those of the control group ( Figure 6 ). On the contrary, MAR decreased a little than the control group. The static parameters of the restricted diet group were similar to those of the control group.
DISCUSSION
In the present 13-week study, the osteoblast surface, osteoid volume, osteoid surface, percent labeled perimeter, and osteocalcin, which are parameters of bone formation, increased. Osteocalcin a strongly expressed osteoblast marker, was markedly increased. The calcification parameter decreased a little. The Berlin blue-positive line was observed at the osteoid-mineralized bone interface and the bone surface seemed to accompany the accumulation of osteoid. Owing to the time lag between the deposition of osteoid and calcification, MLT was markedly increased.
As a result of the marked decrease of the bone volume in the early stage of the administration, deep resorption cavities became bone formation sites. On the other hand, during the administration period, the accumulation of iron deposition on the bone surface increased. This increase may obstruct the communication of osteoblast and osteocyte and suppress mineralization. In other words, it is thought to be the iron lactate acting to dynamicly augment osteoblast recruitment that leads to massive accumulation of osteoid exceeding the capacity of mineralization. Thus, osteoblast recruitment may exceed that of mineralization or the iron inside the osteoblasts along the trabecular bone may suppress the remodeling and lead to hyperosteoidosis.
The food consumption of the iron lactate-exposure group varied from 61% to 88% of the control group. The restricted 
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MATSUSHIMA ET AL TOXICOLOGIC PATHOLOGY diet group sets the condition that is more severe than these values. In the present study, no remarkable changes were observed in the static parameters of the secondary spongiosa in the restricted diet group. However, in a report by Kawabata et al, in a 65% restricted diet in spontaneously hypertensive rats, the volume density and mean thicknesses of the trabecular bone decreased in areas adjacent to the proximal femoral growth plate (11) . It should be taken into account that the decrease of food consumption has an influence on the primary spongiosa and growth plate of the tibia. As another factor, the alteration in bone kinetics may have been secondary to altered function of osteoclasts or osteoblasts as a result of diet restriction. Since a change in the number of osteoclast was not observed in the study of Narama et al (17) , in our study, we did not measure the biochemical marker of osteoclast. There was no need to measure this parameter because there was no change in the osteoclast number per mm of bone surface and osteoclast surface.
In our previous study, the short-term exposure of iron lactate (for 2 and 4 weeks) resulted in marked bone resorption and bone formation. However, due to coincidentally marked bone resorption, the net bone volume decreased (15) . Shortterm exposure to iron lactate led to osteoporotic bone lesions but to osteomalacic bone lesions in the advanced stage on prolonged exposure. This seems to reflect the fact that bone resorption advances rapidly in the early period of iron lactate exposure, while bone formation progress from the middle to the end of the exposure period. There is no iron deposition on the bone surface in the short-term exposure of iron lactate. It is thought that the mechanism of bone lesion development might be due to ferrous iron mediated hydroxy radical formation or decrease of pH by oxidative stress (15) .
PTH secretion was similar in the short-and 13-weekexposure of iron lactate and was low in these studies. Low turnover osteomalacia has been reported with iron-induced osteomalacia and accompanies low PTH secretion. The osteoid is not mineralized and accumulates on the bone surface in layers of excessive thickness. Osteoblasts, osteoclasts and labeled surfaces are not manifested, and bone formation and resorption are even further decreased (22, 26) . Low PTH secretion and histopathological changes in these events are similar to those observed in our experiments; however, the parameters of bone formation are different.
Brent et al demonstrated that hypercalcemia by infusion of calcium gluconate would result in a modest suppression of PTH from baseline values (2) . Studies of parathyroid cells in culture have provided important information on the mechanism of PTH secretion. A low concentration of extracellular calcium stimulates parathyroid cells and leads to PTH secretion, while a high concentration of extracellular calcium suppresses it (3). -Proximal tibial metaphysis from a male rat exposed to 50,000 ppm iron lactate for 13 weeks. Bone volume decreases in the secondary spongiosa compared with the control rat. Goldner's Masson trichrome. 4.-Tibia from a male rat exposed to 50,000 ppm iron lactate for 13 weeks. Lamellar osteoids (arrows) are seen at the surface of trabecular bone. Inset: Tibia from a control male rat. Goldner's Masson trichrome. 5.-Tibia from a male rat exposed to 50,000 ppm iron lactate for 13 weeks. Lining iron deposition can be seen on the osteoid-mineralized bone interface along the trabecular surface. Inset: Tibia from a control male rat. Berlin blue. 6.-Tibia from a male rat exposed to 50,000 ppm iron lactate for 13 weeks. Double and single tetracycline labeling can be seen on the trabecular surface. Inset: Tibia from a control male rat. Fluorescence photomicrographs.
Iron lactate-induced eosinophilic gastroenterocolitis has been reported to lead to reduction of body weight (16) . In the present study, eosinophilic infiltration was also observed in the mucosa of the gastrointestinal tracts in the iron lactate exposure group (data not shown), and showed excessive weight loss accompanied by decreased serum protein level. Levin et al described that the decrease of total serum protein was observed in the severely restricted male group (food intake: 25% of control) with remarkably decreased body weight (12) . Since this food intake is more severe than in the iron lactate exposure group, the decreased serum protein is likely caused by eosinophilic gastroenterocolitis. Lorenzo et al suggested that a lower serum phosphorus level due to spontaneous reduction of protein intake might contribute to the relatively low PTH levels observed in elderly hemodialysis patients (13) . This decreased serum protein due to the gastroenterocolitis may have led to the low PTH (1, 13) .
In addition, Narama et al demonstrated that the hepatocytes and renal tubular epithelial cells received toxic injury in ironoverloaded rats, because increased serum levels of transaminase, creatinine, and urea nitrogen were attributable to the impaired function of the liver and kidney (17) . In the present study, iron positive granules were present in the proximal tubular epithelial cells and serum urea nitrogen also showed high values. However, in the study of Levin et al, after a decrease of 50% in food intake, serum transaminase and urea nitrogen level dose not change (12) . Therefore, we believe that it is the iron lactate that influenced the functional effects on renal tubular metabolism. Sato et al also described that osteomalacia was due to a combined effect of low 1αhydroxylase and low serum phosphorus due to an effect of saccharated ferric oxide on renal tubular epithelium (24) . It is considered that iron lactate also impairs the proximal renal tubular function and may lead to the abnormal values of blood biochemistry and urinalysis. In other words, the low PTH promotes the reabsorption of phosphorus from the urine and suppresses the reabsorption of calcium and leads to hypophosphatemia and hypercalcemia.
Iron and aluminum, in concentrations similar to those observed in patients who are undergoing long-term hemodialysis, blood transfusion, or chalybeate administration, have been reported to decrease PTH secretion during hypocalcemia (14, 22) . Felsenfeld et al suggested that high serum aluminum levels might decrease PTH secretion (7). Brown et al described the relative potencies of extracellular calcium and magnesium in inhibiting PTH release and dopaminestimulating cAMP accumulation in dispersed bovine parathyroid cells (4). In the presence of extracellular magnesium, raising extracellular calcium concentration in a stepwise fashion increases cytosolic calcium in parallel with a concomitant decrease of PTH release (5). These results described that Figures 1-6 
